GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease.
Saved in:
| Title: | GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease. |
|---|---|
| Authors: | Wu SS; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Hung PY; Gilva Therapeutics Co., Ltd., Taipei 100, Taiwan., Yeh TY; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Lin PJ; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan., Chern JW; Gilva Therapeutics Co., Ltd., Taipei 100, Taiwan., Yu CW; School of Pharmacy, College of Medicine, National Taiwan University, Taipei 100, Taiwan. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2026 May 14; Vol. 69 (9), pp. 10122-10139. Date of Electronic Publication: 2026 Apr 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1520-4804 |
|---|---|
| DOI: | 10.1021/acs.jmedchem.5c03139 |
